Fluoropassivation and gelatin sealing of polyester arterial prostheses to skip preclotting and constrain the chronic inflammatory response

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 93, Issue 2, 2010, Pages 497-509

  Xie, Xingyi ^a,b   Guidoin, Robert ^b   Nutley, Mark ^b   Zhang, Ze ^b  

^a SICHUAN UNIVERSITY   (China)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Fluorine; Fluoropassivation; Gelatin; Polyester; Vascular prosthesis

Indexed keywords

BIOLOGICAL ENVIRONMENTS; CHRONIC INFLAMMATORY; CRYSTALLINITIES; FLUORINE CONTENT; FLUOROPASSIVATION; FLUOROPOLYMER; GELATIN COATINGS; IN-VITRO; IN-VIVO; MARGINAL EFFECTS; ORIGINAL MODEL; PET FIBERS; POLYESTER FIBER; POLYESTER VASCULAR PROSTHESIS; VASCULAR PROSTHESIS; WATER PERMEABILITY;

BLOOD VESSEL PROSTHESES; COATINGS; FLUORINE; MECHANICAL PROPERTIES; PHOTORESISTS; POLYETHYLENE TEREPHTHALATES; SURFACES; THERMOPLASTICS;

SURFACE MORPHOLOGY;

FLUORINE; GELATIN; POLITEF; POLYESTER; POLYETHYLENE TEREPHTHALATE; WATER;

ANIMAL TISSUE; ARTERY PROSTHESIS; ARTICLE; BLOOD CLOTTING; CHEMICAL PROCEDURES; CHEMICAL STRUCTURE; CHEMISTRY; CHRONIC INFLAMMATION; CONTROLLED STUDY; CRYSTALLIZATION; ENVIRONMENT; FLUOROPASSIVATION; GELATIN SEALING; HYDROPHILICITY; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; MELTING POINT; MORPHOLOGY; NONHUMAN; RIGIDITY; STRENGTH; WATER PERMEABILITY;

ANIMALS; ARTERIES; BLOOD COAGULATION; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; DOGS; FLUORINE; GELATIN; HYDROPHOBICITY; IMPLANTS, EXPERIMENTAL; INFLAMMATION; MATERIALS TESTING; POLYETHYLENE TEREPHTHALATES; POLYTETRAFLUOROETHYLENE; SURFACE PROPERTIES; TIME FACTORS;

COATINGS; FLUORINE; GELATIN; PASSIVITY; POLYETHYLENE TEREPHTHALATE; SURFACES; THERMOPLASTICS;

EID: 77951173390     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31609     Document Type: Article

References (76)

1. Xue L, Greisler HP. Biomaterials in the development and future of vascular grafts. J Vasc Surg 2003;37:472-480. (Pubitemid 36236932)
2. Kapadia MR, Popowich DA, Kibbe MR. Modified prosthetic vascular conduits. Circulation 2008;117:1873-1882.
3. Guidoin R, Couture J, Assayed F, Gosselin C. New frontiers of vascular grafting. Int Surg 1988;73:241-249.
4. Crawford ES, DeBakey ME, Cooley DA, Morris GC Jr. Surgical considerations of aneurysms and atherosclerotic occlusive lesions of the aorta and major arteries. Postgrad Med 1961;29:151-163.
5. Pearce WH, Zarins CK, Bacharach JM. Atherosclerotic peripheral vascular disease symposium II: Controversies in abdominal aortic aneurysm repair. Circulation 2008;118:2860-2863.
6. Freeman Z, Freeman A. Coronary by-pass surgery: A reappraisal. Aust N Z J Med 1982;12:309-320.
7. Hiatt WR, Goldstone J, Smith SC Jr, McDermott M, Moneta G, Oka R, Newman AB, Pearce WH. Atherosclerotic peripheral vascular disease symposium II: Nomenclature for vascular diseases. Circulation 2008;118:2826-2829.
8. Pomposelli FB, Kansal N, Hamdan AD, Belfield A, Sheahan M, Campbell DR, Skillman JJ, Logerfo FW. A decade of experience with dorsalis pedis artery bypass: Analysis of outcome in more than 1000 cases. J Vasc Surg 2003;37:307-315. (Pubitemid 36236907)
9. Shi Y, O'Brien JE, Mannion JD, Morrison RC, Chung W, Fard A, Zalewski A. Remodeling of autologous saphenous vein grafts: The role of perivascular myofibroblasts. Circulation 1997;95: 2684-2693. (Pubitemid 27255498)
10. Kieffer E, Gomes D, Chiche L, Fléron M-H, Koskas F, Bahnini A. Allograft replacement for infrarenal aortic graft infection: Early and late results in 179 patients. J Vasc Surg 2004;39:1009-1017. (Pubitemid 38581631)
11. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, Golding LA, Gill CC, Taylor PC, Sheldon WC, Proudfit W. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. New Engl J Med 1986;314:1-6.
12. Hughes C, Domenig CM, Hamdan AD, Schermerhorn M, Aulivola B, Blattman S, Campbell DR, Scovell SD, LoGerfo FW, Pomposelli FB Jr. Bypass to plantar and tarsal arteries: An acceptable approach to limb salvage. J Vasc Surg 2004;40:1149-1157. (Pubitemid 40037283)
13. Labbé R, Douville Y, Noël HP. Arterial reconstruction to the foot vessels: Is it worth the trouble? Can J Surg 1989;32:424-427.
14. Koebelé F, Guidoin R, Fabre JL, Bronn P, Goeau-Brissonnière O, Marois M, Gosselin C, Blais P. Venous homografts as femoropopliteal bypasses or as vascular access routes in chronic hemodialysis. J Chir (Paris) 1984;121:283-292.
15. Charara J, Beaudoin G, Fortin C, Guidoin R, Roy PE, Marble A, Schmitter R, Paynter R. In vivo biostability of four types of arterial grafts with impervious walls: Their haemodynamic and pathological characteristics. J Biomed Eng 1989;11:416-428.
16. Gill F, Guzman R, Guidoin R, Avril G, Charara J, Batt M, Roy PE, Marois M, Graham AM, Symes JF, Ricci M. A histo-morphological evaluation of ninety surgically excised human umbilical vein grafts. J Biomed Mater Res 1989;23 (A3 Suppl):363-380. (Pubitemid 20043996)
17. Batt M, Avril G, Gagliardi JM, Guzmab R, Guidoin R, Boas N, Daune B, Hassen-Khodja R, le Bas P. Femorodistal bypass using the chemically processed human umbilical vein graft: 9-year experience. Can J Surg 1990;33:61-65. (Pubitemid 20131527)
18. Guidoin R, Marois D, Zelter J, Bonnaud P, Marois M, Leblond P, Sheiner N, Gosselin C, Roy P. Progressive complications associated with the use of a bovine heterograft for vascular access. Can J Surg 1984;27:72-77. (Pubitemid 14126644)
19. Guidoin R, Thévenet A, Noël HP, Mary H, Marois MK, Gosselin C, King M. The Sparks-Mandril arterial prosthesis. An ingenious concept, a total failure. What can we learn from it?J Mal Vasc 1984;9: 277-283.
20. Germain L, Rémy-Zolghadri M, Auger F. Tissue engineering of the vascular system: From capillaries to larger blood vessels. Med Biol Eng Comput 2000;38:232-240. (Pubitemid 30193000)
21. L'Heureux N, Pâquet S, Labbé R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J 1998;12:47-56. (Pubitemid 28060270)
22. Botzko K, Synder R, Larkin J, Edwards WS. In vivo/in vitro life testing of vascular prostheses. In: Syrett BC, Adrarya A, editors. Corrosion and Degradation of Implant Materials. Philadelphia: ASTM STP 684, American Society for Testing and Materials;1979. pp 76-88.
23. Couture J, Guidoin R, King M, Marois M. Textile Teflon arterial prostheses: How successful are they?Can J Surg 1984;27:575-582.
24. Synder RW, Botzko KM. Woven knitted and externally supported DacronVR vascular prostheses. In: Stanley JC, Burkel WE, Lindenauer SM, Bartlett RH, Turcotte JG, editors. Biologic and Synthetic Vascular Prostheses. New York: Grune & Stratton; 1982. pp 485-494.
25. DeBakey ME, Jordan GL, Abbott JP, Halpert B, O'Neal RM. The fate of Dacron vascular grafts. AMA Arch Surg 1964;89:755-782.
26. Legendre JM, de la Faye D, Guidoin R, King M, Lefevre C, Gosselin C. The initial blood retention properties of arterial prostheses. Res Exp Med 1986;186:185-202. (Pubitemid 16088512)
27. Yates SG, Barros d'sa AA, Berger K, Fernandez LG, Wood SJ, Rittenhouse EA, Davis CC, Mansfield PB, Sauvage LR. The preclotting of porous arterial prostheses. Ann Surg 1978;188:611-622.
28. Guidoin R, Synder R, Martin L, Botzko K, Marois M, Awad J, King M, Domurado D, Bedros M, Gosselin C. Albumin coating of a knitted polyester arterial prosthesis: An alternative to preclotting. Ann Thorac Surg 1984;37:457-465. (Pubitemid 14077463)
29. Marois Y, Guidoin R, Couture J, King MW, Martin L, Roy R. The Dialine II graft: A new collagen-impregnated warp-knitted polyester arterial prosthesis. Ann Vasc Surg 1997;11:133-140. (Pubitemid 27164352)
30. Ukpabi P, Marois Y, King M, Deng X, Martin L, Laroche G, Douville Y, Guidoin R. The Gelweave polyester arterial prosthesis. Can J Surg 1995;38:322-331.
31. Guidoin R, Marceau D, Couture J, Rao TJ, Merhi Y, Roy PE, DeLa- Faye D. Collagen coatings as biological sealants for textile arterial prostheses. Biomaterials 1989;10:156-165. (Pubitemid 19120669)
32. Chakfé N, Bizonne SC, Beaufigeau M, Urban E, Cardon A, Doillon C, Le Magnen JF, Durand B, Kretz JG. Impregnated polyester arterial prostheses: Performance and prospects. Ann Vasc Surg 1999; 13:509-523. (Pubitemid 29424479)
33. Merhi Y, Guidoin R, Forest JC. Fate of polyester arterial prostheses implanted as thoraco-abdominal by-passes in dogs: Haematology, pathology, and biochemistry. Clin Invest Med 1988;11: 403-416. (Pubitemid 19011515)
34. Deng X, Guidoin R. Alternative blood conduits: Assessment of whether the porosity of synthetic prostheses is the key to longterm biofunctionality. Med Biol Eng Comput 2000;38:219-225. (Pubitemid 30192998)
35. Shi Q, Wu MHD, Onuki Y, Ghali R, Hunter GC, Johansen KH, Sauvage LR. Endothelium on the flow surface of human aortic Dacron vascular grafts. J Vasc Surg 1997;25:736-742. (Pubitemid 27190940)
36. Sinzinger H, Silberbauer K, Winter M, Auerswald W. Relation between fibrinolytic activity and prostacyclin generation of atherosclerotic artery and Dacron prosthetic graft. Experientia 1979;35: 785-786. (Pubitemid 9193898)
37. Bunting S, Moncada S, Vane JR. The prostacyclin-thromboxane- A2 balance: Pathophysiological and therapeutic implications. Br Med Bull 1983;39:271-276. (Pubitemid 13063958)
38. Moncada S, Herman AG, Higgs EA, Vane JR. Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thromb Res 1977;11:323-344. (Pubitemid 8160330)
39. Henderson VJ, Cohen RG, Mitchell RS, Kosek JC, Miller DC. Biochemical (functional) adaptation of "arterialized" vein grafts. Ann Surg 1986;203:339-345.
40. Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 2006;147 (Suppl 1):S193-S201.
41. Berger K, Sauvage LR, Rao AM, Wood SJ. Healing of arterial prostheses in man: Its incompleteness. Ann Surg 1972;175:118-127.
42. Merhi Y, Bernier J, Marois Y, Guidoin R. Acute thrombogenicity of arterial prostheses exposed to reduced blood-flow in dogs: Effects of heparin, aspirin, and prostacyclin. J Cardiovasc Pharmacol 1995;26:1-5.
43. Guidoin R, King M, Blais P, Marois M, Gosselin C, Roy P, Courbier R, David M, Noël HP. A biological and structural evaluation of retrieved Dacron aterial prostheses. In: Weinstein A, Gibbon D, Brown S, Ruff W, editors. Implant Retrieval: Material and Biological Analysis. Washington DC: NBS Special Publication 601, National Bureau of Standards; 1981. pp 29-129; sp601.
44. Matsumoto H, Hasegawa T, Fuse K, Yamamoto M, Saigusa M. New vascular prosthesis for a small caliber artery. Surgery 1973; 74:519-523.
45. Boyce B. Physical characteristics of expanded polytetrafluoroethylene grafts. In: Stanley JC, Burkel WE, Lindenauer SM, Bartlett RH, Turcotte JG, editors. Biologic and Synthetic Vascular Prostheses. New York: Grune & Stratton;1982. pp 553-561.
46. Hamlin GW, Rajah SM, Crow MJ, Kester RC. Evaluation of the thrombogenic potential of three types of arterial graft studied in an artificial circulation. Br J Surg 1978;65:272-276.
47. Formichi MJ, Guidoin RG, Jausseran JM, Awad JA, Johnston KW, King MW, Eng P, Courbier R, Marois M, Rouleau C. Expanded PTFE prostheses as arterial substitutes in humans: Late pathological findings in 73 excised grafts. Ann Vasc Surg 1988;2:14-27.
48. Graham LM, Bergan JJ. Expanded polytetrafluoroethylene vascular grafts: Clinical and experimental observations. In: Stanley JC, Burkel WE, Lindenauer SM, Bartlett RH, Turcotte JG, editors. Biologic and Synthetic Vascular Prostheses. New York: Grune & Stratton;1982. pp 563-586.
49. Begovac PC, Thomson RC, Fisher JL, Hugshon A, Gällhagen A. Improvements in Gore-Tex® vascular graft performance by Carmeda® bioactive surface heparin immobilization. Eur J Vasc Endovasc Surg 2003;25:432-437. (Pubitemid 36603293)
50. Paton DM, Ashton TR, Maini R. Fluorinating polymer surfaces. US Patent No.5,356,668,1994.
51. Rhee RY, Gloviczki P, Cambria RA, Miller VM. Experimental evaluation of bleeding complications, thrombogenicity and neointimal characteristics of prosthetic patch materials used for carotid angioplasty. Cardiovasc Surg 1996;4:746-752. (Pubitemid 27061903)
52. Chinn JA, Sauter JA, Phillips RE Jr, Kao WJ, Anderson JM, Hanson SR, Ashton TR. Blood and tissue compatibility of modified polyester: Thrombosis, inflammation, and healing. J Biomed Mater Res 1998;39:130-140.
53. Marois Y, Zhang Z, Vert M, Beaulieu L, Lenz RW, Guidoin R. In vivo biocompatibility and degradation studies of polyhydroxyoctanoate in the rat: A new sealant for the polyester arterial prosthesis. Tissue Eng 1999;5:369-386.
54. Meerwaldt R, Lansink KWW, Blomme AM, Fritschy WM. Prospective randomized study of carotid endarterectomy with fluoropassiv TM thin wall carotid patch versus venous patch. Eur J Vasc Endovasc Surg 2008;36:45-52. (Pubitemid 351876161)
55. Guidoin R, Marois Y, Zhang Z, King M, Martin L, Laroche G, Awad J. The benefits of fluoropassivation of polyester arterial prostheses as observed in a canine model. ASAIO J 1994;40: M870-M879. (Pubitemid 24364325)
56. Ao PY, Hawthorne WJ, Vicaretti M, Fletcher JP. Development of intimal hyperplasia in six different vascular prostheses. Eur J Vasc Endovasc Surg 2000;20:241-249.
57. Soares BM, Guidoin RG, Marois Y, Martin L, King MW, Laroche G, Zhang Z, Charara J, Girard JF. In vivo characterization of a fluoropassivated gelatine impregnated polyester mesh for hernia repair. J Biomed Mater Res 1996;32:293-305.
58. Kimber CP, Dunkley MP, Haddock G, Robertson L, Carey FA, Cuschieri A. Patch incorporation in diaphragmatic hernia. J Pediatr Surg 2000;35:120-123.
59. Zhang Z, Guidoin R, King MW, How TV, Marois Y, Laroche G. Removing fresh tissue from explanted polyurethane prostheses: Which approach facilitates physico-chemical analysis?Biomaterials 1995;16:369-380.
60. Zhang Z, King M, Guidoin R, Therrien M, Pezolet M, Adnot A, Ukpabi P, Vantal MH. Morphological, physical and chemical evaluation of the Vascugraft® arterial prosthesis: Comparison of a novel polyurethane device with other microporous structures. Biomaterials 1994;15:483-501. (Pubitemid 24180616)
61. Guidoin R, King MW, Marceau D, Cardou A, De la Faye D, Legendre JM, Blais P. Textile arterial prostheses: Is water permeability equivalent to porosity?J Biomed Mater Res 1987;21: 65-87.
62. Cardiovascular implants-Tubular vascular prostheses. ANSI/AAMI/ ISO 7198 1998-2001, Arlington, VA, Association for the Advancement of Medical Instrumentation,1998.
63. Mehta A, Gaur U, Wunderlich B. Equilibrium melting parameters of poly(ethylene terephthalate). J Polym Sci Polym Phys Ed 1978; 16:289-296. (Pubitemid 8576743)
64. Zhang Z, King M, Guidoin R, Therrien M, Doillon C, Diehl-Jones WL, Huebner E. In vitro exposure of a novel polyesterurethane graft to enzymes: A study of the biostability of the VascugraftVR arterial prosthesis. Biomaterials 1994;15:1129-1144.
65. Clark DT, Thomas HR. Applications of ESCA to polymer chemistry. XVII. Systematic investigation of the core levels of simple homopolymers. J Polym Sci Polym Chem Ed 1978;16:791-820.
66. Clark DT, Feast WJ, Kilcast D, Musgrave WKR. Application of ESCA to polymer chemistry. III. Structures and bonding in homopolymers of ethylene and the fluoroethylenes and determination of the compostions of fluoro copolymers. J Polym Sci Poly Chem Ed 1973;11:389-411.
67. Napier ME, Stair PC. Decomposition of fluorinated diethers on the clean iron surface. Surf Sci 1993;298:201-214.
68. Napier ME, Stair PC. Decomposition of perfluoro-1-methoxy-2-ethoxy ethane on iron surfaces chemically modified with oxygen. Surf Sci 1994;316:317-328.
69. Deng X, Guidoin R. Arteries, veins and lymphatic vessels. In: Black J, Hastings G, editors. Handbook of Biomaterial Properties. London: Chapman & Hall; 1998. pp 81-105.
70. Konig G, McAllister TN, Dusserre N, Garrido SA, Iyican C, Marini A, Fiorillo A, Avila H, Wystrychowski W, Zagalski K, Maruszewski M, Jones AL, Cierpka L, de la Fuente LM, L'Heureux N. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. Biomaterials 2009;30:1542-1550.
71. Lawton EL, Ringwald EL. Physical constants of poly(oxyethyleneoxyterephthaloyl) (poly(ethylene terephthalate)). In: Polymer Handbook, 3rd edition, Brandrup J, Immergut EH, editors. New York: John Wiley & Sons; 1989, pp 101-106.
72. Rim PB, Nelson CJ. Properties of PET fibers with high modulus and low shrinkage (HMLS). I. Yarn properties and morphology. J Appl Polym Sci 1991;42:1807-1813.
73. Hoffman AS, Garfinkle AM, Ratner BD, Hanson SR. Plasma gas discharge treatment for improving the compatibility of biomaterials. US Patent No.5,034,265,1991.
74. Lafrenière-Gagnon D, Guidoin R, Roy PE, Martin L, Douville Y, Bernard PM. Etude morphométrique de la cicatrisation d'une prothèse artérielle en polyester traitée avec un plasma de fluoroéthylène et implantée chez le chien. Rev Europ Technol Biomed 1990;11:300-309.
75. Parker NR, Caywood DD, Shankerelli K, Hall A III. A study to compare the healing of a plasma-TFE synthetic artery in the dog. J Invest Surg 1989;2:457-470. (Pubitemid 20143854)
76. Guidoin R, King M, Therrien M, Paynter R, Simoneau S, Debille E, Tremblay L, Boyer D, Gill F. The Atrium plasma TFE® arterial prosthesis: Physical and chemical characterization. In: Szycher M, editor. High Performance Biomaterials - A Comprehensive Guide to Medical and Pharmaceutical Applications. Lancaster: Technomic Publishing; 1991. pp 381-399.